Skip to main content

Market Overview

A Couple Of News Dumps You May Have Missed On Tuesday Night

Share:

The entire nation was glued to their TV sets or smartphones for the latest U.S. election updates. This also proved to be a convenient time for companies to release a "news dump" - a potentially negative news release on a much bigger news day.

Intentional or not, the following reports and announcements were released Tuesday evening, which coincided with the presidential election coverage.

GoPro Recalls Drones

GoPro Inc (NASDAQ: GPRO) announced that a safety issue involving its new drone product has prompted a full recall.

GoPro sold approximately 2,500 units of its drone, called Karma, but consumers are now urged to return the drone to their point of purchase after the company discovered that a "very small number of cases" of drones lost power while flying in the air.

Arrowhead Pharmaceuticals Issues FDA Update

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) announced an update to an ongoing clinical trial called Heparc-2004, which is evaluating its ARC-520 drug for the treatment of chronic hepatitis B virus infections.

Arrowhead said it was notified by the U.S. Food & Drug Administration that the agency is requesting the company put its clinical trial on hold.

Arrowhead was also requested to submit responses to the FDA's questions and concerns. The company did note that the clinical hold was not based on any human findings.

 

Related Articles (ARWR + GPRO)

View Comments and Join the Discussion!

Posted-In: GoPro Karma News DumpNews

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com